Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_38839 | 18 | 0.37 | Mlig455_067019 | Neo: - Age: - |
Mlig455_067019 {REF} {Length: 1403} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=59.4]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.6]} {Smed: dd_Smed_v6_42389_0_1, dd_Smed_v6_42389_0_1, [RH, Score=141, Expect=1e-38]} {RNA1310_19511} {RNA815_7578} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.759 | 0.778 | 0.99973 | 1.00000 | |
RegionR2 | 3.056 | 0.778 | 0.99687 | 1.00000 | |
RegionR3 | 2.666 | 0.778 | 0.76102 | 1.00000 | |
RegionR4 | -0.104 | 0.778 | 0.99952 | 1.00000 | |
RegionR5 | -0.961 | 0.778 | 0.99986 | 1.00000 | |
RegionR6 | -1.495 | 0.778 | 0.99965 | 1.00000 | |
RegionR7 | -1.444 | 0.778 | 0.99972 | 1.00000 | |
RegionR8 | -0.958 | 0.778 | 0.99967 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.966 | 0.778 | 0.99980 | 1.00000 | |
RegenerationR2 | -1.029 | 0.778 | 0.79504 | 0.98809 | |
RegenerationR3 | -3.674 | 0.778 | 0.10553 | 0.51423 | |
RegenerationR4 | -0.333 | 0.778 | 0.99076 | 1.00000 | |
RegenerationR5 | -0.87 | 0.778 | 0.99973 | 1.00000 | |
RegenerationR6 | 1.106 | 0.778 | 0.80217 | 0.97825 | |
RegenerationBL | -0.881 | 0.778 | 0.99991 | 1.00000 | |
RegenerationTP | -0.826 | 0.778 | 0.99976 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_38839 | 18 | 0.37 | Mlig455_067019 | Neo: - Age: - |
4 | 1.000 | - | 1.000 | 1.000 | 1.000 | - | Mlig455_067019 {REF} {Length: 1403} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=59.4]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.6]} {Smed: dd_Smed_v6_42389_0_1, dd_Smed_v6_42389_0_1, [RH, Score=141, Expect=1e-38]} {RNA1310_19511} {RNA815_7578} | |
2. | MligTC455_13376 | 101 | 2.1 | Mlig455_040613 | Neo: - Age: - Region-specific R2: 4.973 Region-enriched R2: 6.158/0.00016 |
2.816 | 0.978 | - | - | 0.842 | 0.996 | - | Mlig455_040613 {REF} {Length: 2807} {RNA1310_27894} {RNA815_60961} | |
3. | MligTC455_13375 | 48 | 1 | Mlig455_008269 | Neo: - Age: - Region-enriched R2: 6.043/0.00338 |
2.742 | 0.975 | - | - | 0.822 | 0.945 | - | Mlig455_008269 {REF} {Length: 2598} {RNA1310_27894} {RNA815_60961} | |
4. | MligTC455_37338 | 40 | 0.84 | Mlig455_035280 | Neo: - Age: - |
2.621 | 0.836 | - | 0.964 | 0.821 | - | - | Mlig455_035280 {REF} {Length: 2442} {RNA1310_17149} {RNA815_15957} | |
5. | MligTC455_19523 | 57 | 1.19 | Mlig455_010252 | Neo: - Age: - Region-enriched R2: 4.866/0.01405 |
2.546 | 0.973 | - | 0.765 | - | 0.808 | - | Mlig455_010252 {REF} {Length: 1178} {RNA1310_30823} {RNA815_27110} | |
6. | MligTC455_36995 | 217 | 4.52 | Mlig455_040359 | Neo: - Age: Down-Up-Up Region-enriched R2: 6.534/0.00155 |
2.544 | 0.771 | - | 0.953 | 0.820 | - | - | Mlig455_040359 {REF} {Length: 759} {RNA1509_59636} {RNA1310_6145.1, RNA1509_59636} {RNA1509_59636, RNA815_27612} | |
7. | MligTC455_52122 | 1435 | 29.9 | Mlig455_035226, Mlig455_035273 | Neo: - Age: - Region-enriched R3: 3.936/0.00000 |
2.503 | 0.739 | - | 0.967 | 0.797 | - | - | Mlig455_035226 {REF} {Length: 725} {TRANSSPLICED} {RNA1509_39421} {RNA1310_8553.2, RNA1509_39421} {RNA1509_39421, RNA815_2974.1} Mlig455_035273 {REF} {Length: 1422} {RNA1509_24257, RNA1509_39421} {RNA1310_8553.2, RNA1509_24257} {RNA1509_24257, RNA815_2974.1} |
|
8. | MligTC455_08037 | 13 | 0.27 | Mlig455_037418, Mlig455_037484 | Neo: - Age: - |
CHRNB2, HTR3E | 1.938 | - | - | 0.979 | - | 0.959 | - | Mlig455_037418 {REF} {Length: 1268} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=102.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=75.2]} {Human: ENSG00000160716, CHRNB2, cholinergic receptor nicotinic beta 2 subunit, [Score=129, Expect=3e-32]; ENSG00000186038, HTR3E, 5-hydroxytryptamine receptor 3E, [Score=128, Expect=3e-32]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=127, Expect=2e-31]; ENSG00000178084, HTR3C, 5-hydroxytryptamine receptor 3C, [Score=126, Expect=2e-31]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=125, Expect=4e-31]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=124, Expect=7e-31]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=123, Expect=3e-30]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=130, Expect=5e-33]; ENSMUSG00000027950, Chrnb2, cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), [Score=127, Expect=6e-32]; ENSMUSG00000041189, Chrnb1, cholinergic receptor, nicotinic, beta polypeptide 1 (muscle), [Score=124, Expect=1e-30]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=137, Expect=3e-35]} {Celegans: WBGene00017580, lgc-4, Ligand-gated ion channel 4, [Score=142, Expect=1e-36]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=134, Expect=2e-34]} {RNA1509_53098} {RNA1310_100091} {RNA815_45198} Mlig455_037484 {REF} {Length: 1840} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=75.2]} {Human: ENSG00000186038, HTR3E, 5-hydroxytryptamine receptor 3E, [Score=129, Expect=9e-33]; ENSG00000178084, HTR3C, 5-hydroxytryptamine receptor 3C, [Score=127, Expect=7e-32]; ENSG00000160716, CHRNB2, cholinergic receptor nicotinic beta 2 subunit, [Score=127, Expect=7e-32]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=127, Expect=1e-31]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=125, Expect=4e-31]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=125, Expect=9e-31]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=130, Expect=4e-33]; ENSMUSG00000027950, Chrnb2, cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), [Score=127, Expect=1e-31]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=135, Expect=1e-34]} {Celegans: WBGene00001133, eat-2, Neuronal acetylcholine receptor subunit eat-2, [Score=137, Expect=5e-36]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=130, Expect=2e-33]} {RNA1509_53098} {RNA1310_100091} {RNA815_45198} |
9. | MligTC455_21757 | 26 | 0.53 | Mlig455_057867 | Neo: - Age: - |
1.936 | 0.953 | - | - | - | 0.983 | - | Mlig455_057867 {REF} {Length: 284} {NoTransDecoderORF} {RNA1310_117997} | |
10. | MligTC455_16060 | 22 | 0.47 | Mlig455_044243 | Neo: - Age: Down-Up-Down |
CFAP157 | 1.924 | 0.969 | - | - | - | 0.955 | - | Mlig455_044243 {REF} {Length: 2694} {TRANSSPLICED} {Pfam: Siphovirus Gp157 [PF05565.13, score=20.7]; Protein of unknown function, DUF573 [PF04504.16, score=20.6]} {Human: ENSG00000160401, CFAP157, cilia and flagella associated protein 157, [Score=106, Expect=5e-24]} {Mouse: ENSMUSG00000038987, Cfap157, cilia and flagella associated protein 157, [Score=110, Expect=3e-25]} {Dmel: FBgn0036962, CG17122, [Score=67.8, Expect=1e-11]} {Smed: dd_Smed_v6_11523_0_1, dd_Smed_v6_11523_0_1, [Score=60.8, Expect=1e-09]} {RNA1509_42697} {RNA1310_10711, RNA1509_42697} {RNA1509_42697, RNA815_24261} |
11. | MligTC455_46823 | 69 | 1.44 | Mlig455_040455, Mlig455_042847 | Neo: - Age: - Region-enriched R2: 5.281/0.02950 |
ANGPTL2 | 1.921 | 0.937 | - | - | - | 0.984 | - | Mlig455_040455 {REF} {Length: 1444} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=152.3]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=129, Expect=8e-34]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=129, Expect=9e-34]; ENSG00000085265, FCN1, ficolin 1, [Score=128, Expect=1e-34]; ENSG00000160339, FCN2, ficolin 2, [Score=125, Expect=1e-33]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=132, Expect=4e-35]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=129, Expect=6e-34]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=127, Expect=3e-33]} {Dmel: FBgn0033312, CG8642, [Score=117, Expect=4e-30]} {Celegans: WBGene00017013, ensh-1, [Score=55.1, Expect=2e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=111, Expect=2e-27]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3} Mlig455_042847 {REF} {Length: 1175} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=154.0]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=132, Expect=7e-35]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=132, Expect=1e-34]; ENSG00000085265, FCN1, ficolin 1, [Score=130, Expect=2e-35]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=126, Expect=1e-32]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=136, Expect=2e-36]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=132, Expect=5e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=130, Expect=1e-34]} {Dmel: FBgn0033312, CG8642, [Score=117, Expect=4e-30]} {Celegans: WBGene00017013, ensh-1, [Score=57.4, Expect=3e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=114, Expect=2e-28]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3} |
12. | MligTC455_39096 | 110 | 2.29 | Mlig455_019781, Mlig455_019803 | Neo: - Age: - |
1.919 | 0.924 | - | - | - | 0.995 | - | Mlig455_019781 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=65.0]} {RNA1310_34740} {RNA815_15663} Mlig455_019803 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.1]} {RNA1310_34740} {RNA815_15663} |
|
13. | MligTC455_16667 | 20 | 0.42 | Mlig455_040694, Mlig455_064563 | Neo: - Age: - |
1.907 | - | - | 0.938 | - | 0.969 | - | Mlig455_040694 {REF} {Length: 1748} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=18.9]} {Smed: dd_Smed_v6_29877_0_1, dd_Smed_v6_29877_0_1, [Score=79.3, Expect=3e-16]} {RNA1310_144465} Mlig455_064563 {REF} {Length: 2190} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.3]} {Smed: dd_Smed_v6_29877_0_1, dd_Smed_v6_29877_0_1, [Score=78.6, Expect=6e-16]} {RNA1310_118049} |
|
14. | MligTC455_43686 | 326 | 6.79 | Mlig455_022166, Mlig455_055777 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.570 Region-enriched R3: 6.671/0.00000 |
1.907 | - | - | 0.996 | 0.911 | - | - | Mlig455_022166 {REF} {Length: 612} {RNA1310_23536} {RNA815_45816} Mlig455_055777 {REF} {Length: 584} {RNA1310_23536} {RNA815_45816} |
|
15. | MligTC455_41673 | 26 | 0.54 | Mlig455_035834 | Neo: - Age: - |
1.896 | - | - | 1.000 | - | 0.896 | - | Mlig455_035834 {REF} {Length: 1561} {NoTransDecoderORF} {RNA1310_64046} {RNA815_37581} | |
16. | MligTC455_45597 | 116 | 2.41 | Mlig455_049417 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.185/0.02405 |
1.893 | 0.937 | - | - | 0.956 | - | - | Mlig455_049417 {REF} {Length: 1106} {RNA1310_45744} {RNA815_56662} | |
17. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
1.889 | 0.905 | - | - | - | 0.984 | - | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
18. | MligTC455_46554 | 47 | 0.97 | Mlig455_038253 | Neo: - Age: logFC(26M/2M)=-0.562 |
1.887 | 0.915 | - | - | - | 0.972 | - | Mlig455_038253 {REF} {Length: 1890} {Pfam: Calcium-activated potassium channel, beta subunit [PF03185.17, score=60.6]} {Smed: dd_Smed_v6_12880_0_1, dd_Smed_v6_12880_0_1, [Score=94.4, Expect=7e-24]} {RNA1310_40614} {RNA815_32173} | |
19. | MligTC455_46649 | 100 | 2.09 | Mlig455_023901 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.216/0.00086 |
SLC46A2 | 1.87 | 0.919 | - | - | - | 0.951 | - | Mlig455_023901 {REF} {Length: 2695} {Pfam: Major Facilitator Superfamily [PF07690.18, score=79.0]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=71.6, Expect=1e-12]} {Mouse: ENSMUSG00000029650, Slc46a3, solute carrier family 46, member 3, [Score=77.4, Expect=1e-14]} {Dmel: FBgn0030576, CG15890, [RH, Score=100, Expect=5e-22]} {Celegans: WBGene00016705, C46C11.2, [RH, Score=95.9, Expect=6e-21]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=344, Expect=1e-113]} {RNA1509_40290} {RNA1310_13436} {RNA815_19265} |
20. | MligTC455_17976 | 81 | 1.68 | Mlig455_002059 | Neo: - Age: - |
1.866 | - | - | 0.914 | - | 0.952 | - | Mlig455_002059 {REF} {Length: 730} {RNA1310_56725} {RNA815_29666} | |
21. | MligTC455_38523 | 93 | 1.94 | Mlig455_042323, Mlig455_047104 | Neo: - Age: - Region-enriched R4: 3.963/0.00013 Regeneration-downregulated R4: -3.333 Regeneration-depleted R4: -3.333 |
1.865 | - | - | - | 0.907 | 0.958 | - | Mlig455_042323 {REF} {Length: 2068} {Pfam: WSC domain [PF01822.21, score=44.5]} {RNA1509_47975} {RNA1310_67186} {RNA815_34468.1} Mlig455_047104 {REF} {Length: 2070} {Pfam: WSC domain [PF01822.21, score=44.5]} {RNA1509_47975} {RNA1310_67186} {RNA815_34468.1} |
|
22. | MligTC455_45039 | 168 | 3.49 | Mlig455_040482, Mlig455_040487 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.332/0.02336 |
1.855 | 0.859 | - | - | - | 0.996 | - | Mlig455_040482 {REF} {Length: 1774} {RNA1310_20941} {RNA815_45079} Mlig455_040487 {REF} {Length: 5763} {tRNA: Val(CAC),pseudo, score=20.2} {Celegans: WBGene00022195, Y71H2B.5, [Score=146, Expect=8e-36]} {Smed: dd_Smed_v6_16438_0_2, dd_Smed_v6_16438_0_2, [Score=188, Expect=1e-49]} {RNA1509_21228} {RNA1310_20941} {RNA815_45079} |
|
23. | MligTC455_32422 | 37 | 0.78 | Mlig455_031348 | Neo: - Age: - |
CHRNA6 | 1.848 | 0.851 | - | 0.997 | - | - | - | Mlig455_031348 {REF} {Length: 1659} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=69.7]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=61.6, Expect=5e-10]; ENSG00000160716, CHRNB2, cholinergic receptor nicotinic beta 2 subunit, [Score=61.2, Expect=8e-10]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=61.2, Expect=5e-10]; ENSMUSG00000027950, Chrnb2, cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), [Score=60.8, Expect=8e-10]; ENSMUSG00000055026, Gabrg3, gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3, [Score=58.5, Expect=4e-09]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [Score=48.5, Expect=4e-06]} {Celegans: WBGene00000057, acr-18, AcetylCholine Receptor; Acetylcholine receptor, one of nine alpha a7-like nicotinic acetylcholine receptor subunits (58.6 kD) (Acr-18), [Score=63.5, Expect=5e-11]} {Smed: dd_Smed_v6_30253_0_1, dd_Smed_v6_30253_0_1, [Score=59.3, Expect=6e-10]} {RNA1310_61084} {RNA815_48984} |
24. | MligTC455_35894 | 23 | 0.48 | Mlig455_029906 | Neo: - Age: - |
RYK | 1.841 | - | - | - | 0.863 | 0.978 | - | Mlig455_029906 {REF} {Length: 3571} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=210.1]; WIF domain [PF02019.20, score=110.2]; Protein kinase domain [PF00069.27, score=79.8]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=202, Expect=7e-57]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [Score=202, Expect=9e-57]} {Dmel: FBgn0015380, drl, derailed, [RH, Score=241, Expect=7e-71]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [RH, Score=179, Expect=9e-49]} {Smed: dd_Smed_v6_12594_0_3, dd_Smed_v6_12594_0_3, [Score=201, Expect=2e-56]} {RNA1509_58811} {RNA1310_6671.2, RNA1509_58811} {RNA1509_58811, RNA815_41921} |
25. | MligTC455_43193 | 359 | 7.49 | Mlig455_033211 | Neo: - Age: - |
1.838 | 0.856 | - | 0.982 | - | - | - | Mlig455_033211 {REF} {Length: 280} {NoTransDecoderORF} {RNA1310_121983} | |
26. | MligTC455_43663 | 88 | 1.83 | Mlig455_070157 | Neo: - Age: Up-Down-Up |
1.836 | 0.868 | - | - | - | 0.968 | - | Mlig455_070157 {REF} {Length: 2611} {RNA1310_65373} {RNA815_37965} | |
27. | MligTC455_13098 | 19 | 0.4 | Mlig455_020992 | Neo: - Age: - |
C1GALT1 | 1.835 | - | - | 0.965 | 0.870 | - | - | Mlig455_020992 {REF} {Length: 1108} {Pfam: Galactosyltransferase [PF01762.23, score=27.6]} {Human: ENSG00000106392, C1GALT1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=160, Expect=3e-46]} {Mouse: ENSMUSG00000042460, C1galt1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1, [Score=162, Expect=1e-46]} {Dmel: FBgn0032078, C1GalTA, Core 1 Galactosyltransferase A, [Score=138, Expect=8e-38]} {Celegans: WBGene00008019, C38H2.2, Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=165, Expect=4e-48]} {Smed: dd_Smed_v6_4310_0_1, dd_Smed_v6_4310_0_1, [Score=185, Expect=3e-56]} {RNA1310_125941} |
28. | MligTC455_14519 | 25 | 0.51 | Mlig455_005304 | Neo: - Age: - |
1.834 | 0.859 | - | - | 0.975 | - | - | Mlig455_005304 {REF} {Length: 1686} {RNA1509_3030} {RNA1310_65512} {RNA815_48423} | |
29. | MligTC455_46512 | 2553 | 53.19 | Mlig455_035211 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.719 Region-enriched R3: 4.974/0.00000 |
1.833 | - | - | 0.966 | 0.867 | - | - | Mlig455_035211 {REF} {Length: 699} {RNA1509_22822, RNA1509_5889} {RNA1310_52884, RNA1509_22822, RNA1509_5889} {RNA1509_22822, RNA1509_5889, RNA815_23505} | |
30. | MligTC455_54779 | 98 | 2.04 | Mlig455_000311 | Neo: - Age: - |
1.828 | - | - | 0.877 | - | 0.951 | - | Mlig455_000311 {REF} {Length: 220} {NoTransDecoderORF} {RNA1310_52315} | |
31. | MligTC455_20088 | 39 | 0.81 | Mlig455_017821 | Neo: - Age: Up-Down-Down |
GLIPR1 | 1.827 | 0.959 | - | - | 0.868 | - | - | Mlig455_017821 {REF} {Length: 2083} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=62.2]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=89.4, Expect=2e-19]} {Mouse: ENSMUSG00000025431, Crisp1, cysteine-rich secretory protein 1, [RH, Score=84.3, Expect=5e-18]} {Dmel: FBgn0038126, CG8483, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=78.6, Expect=5e-16]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=143, Expect=7e-37]} {RNA1310_43937.1} {RNA815_38891} |
32. | MligTC455_31462 | 23 | 0.48 | Mlig455_000844 | Neo: - Age: - |
1.824 | 0.966 | - | - | 0.858 | - | - | Mlig455_000844 {REF} {Length: 2564} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=39.1]} {Smed: dd_Smed_v6_12148_0_2, dd_Smed_v6_12148_0_2, [Score=81.6, Expect=5e-18]} {RNA1509_6604} {RNA1310_43619} {RNA815_6128.2} | |
33. | MligTC455_46502 | 168 | 3.5 | Mlig455_010557 | Neo: - Age: - |
1.823 | 0.967 | - | - | 0.856 | - | - | Mlig455_010557 {REF} {Length: 557} {Pfam: HalX domain [PF08663.12, score=24.3]} {RNA1509_57107} {RNA1310_80026, RNA1509_57107} {RNA1509_57107, RNA815_41799} | |
34. | MligTC455_19277 | 1013 | 21.11 | Mlig455_059600 | Neo: - Age: - Region-specific R2: 4.883 Region-enriched R2: 5.766/0.00000 |
1.817 | 0.860 | - | - | - | 0.957 | - | Mlig455_059600 {REF} {Length: 827} {NoTransDecoderORF} {RNA1509_43907} {RNA1310_81348} | |
35. | MligTC455_37182 | 268 | 5.59 | Mlig455_025551, Mlig455_044649, Mlig455_045911, Mlig455_050796, Mlig455_063331, Mlig455_067253, Mlig455_067538 | Neo: - Age: - Region-enriched R4: 5.183/0.00027 |
KRTAP16-1, PLEKHG7 | 1.817 | - | - | 0.858 | - | 0.959 | - | Mlig455_025551 {REF} {Length: 2105} {Pfam: Pleckstrin homology domain [PF16652.7, score=61.0]; RhoGEF domain [PF00621.22, score=35.5]} {Human: ENSG00000187510, PLEKHG7, pleckstrin homology and RhoGEF domain containing G7, [Score=182, Expect=3e-48]} {Mouse: ENSMUSG00000022957, Itsn1, intersectin 1 (SH3 domain protein 1A), [Score=86.7, Expect=5e-17]} {Dmel: FBgn0261556, CG42674, [Score=73.9, Expect=3e-13]} {Celegans: WBGene00022391, Y95B8A.12, [Score=198, Expect=7e-55]} {Smed: dd_Smed_v6_20050_0_1, dd_Smed_v6_20050_0_1, [Score=338, Expect=2e-105]} {RNA1310_39125} {RNA815_49310} Mlig455_044649 {REF} {Length: 1371} {RNA1509_7410} {RNA1310_24511} {RNA815_4829.2} Mlig455_045911 {REF} {Length: 1780} {Pfam: RNA dependent RNA polymerase [PF12426.10, score=19.3]} {RNA1509_7410} {RNA1310_24511} {RNA815_4829.2} Mlig455_050796 {REF} {Length: 1689} {Pfam: RNA dependent RNA polymerase [PF12426.10, score=22.7]; Phosphoserine phosphatase RsbU, N-terminal domain [PF08673.12, score=19.9]} {RNA1509_7410} {RNA1310_24511} {RNA815_4829.2} Mlig455_063331 {REF} {Length: 1289} {Pfam: RNA dependent RNA polymerase [PF12426.10, score=19.3]} {RNA1509_7410} {RNA1310_616.1} {RNA815_4829.2} Mlig455_067253 {REF} {Length: 1495} {Pfam: RNA dependent RNA polymerase [PF12426.10, score=19.3]} {RNA1509_7410} {RNA1310_24511} {RNA815_4829.2} Mlig455_067538 {REF} {Length: 1899} {Human: ENSG00000263186, KRTAP16-1, keratin associated protein 16-1, [Score=63.5, Expect=3e-11]; ENSG00000212657, KRTAP16-1, keratin associated protein 16-1, [Score=63.5, Expect=3e-11]} {Mouse: ENSMUSG00000078253, Krtap16-1, keratin associated protein 16-1, [Score=70.5, Expect=1e-13]} {RNA1509_7410} {RNA1310_616.1} {RNA815_33844} |
36. | MligTC455_29971 | 111 | 2.31 | Mlig455_006512 | Neo: - Age: - |
CRB2 | 1.816 | 0.952 | - | - | - | 0.864 | - | Mlig455_006512 {REF} {Length: 4810} {Pfam: EGF-like domain [PF00008.29, score=148.0]; Human growth factor-like EGF [PF12661.9, score=63.1]; Laminin G domain [PF02210.26, score=25.7]} {Human: ENSG00000148204, CRB2, crumbs 2, cell polarity complex component, [RH, Score=360, Expect=8e-105]} {Mouse: ENSMUSG00000035403, Crb2, crumbs family member 2, [RH, Score=358, Expect=3e-104]} {Dmel: FBgn0259685, crb, crumbs, [Score=412, Expect=2e-120]} {Celegans: WBGene00018547, clec-78, C-type LECtin, [Score=201, Expect=5e-52]} {Smed: dd_Smed_v6_7067_0_1, dd_Smed_v6_7067_0_1, [Score=230, Expect=3e-61]} {RNA1509_50019} {RNA1310_14888.1} {RNA815_693.1} |
37. | MligTC455_40341 | 106 | 2.2 | Mlig455_060207, Mlig455_070456 | Neo: - Age: Down-Down-Up Region-enriched R2: 6.703/0.00648 |
NPY2R | 1.814 | 0.965 | - | - | 0.849 | - | - | Mlig455_060207 {REF} {Length: 3062} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=177.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=47.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=29.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.6]} {Human: ENSG00000185149, NPY2R, neuropeptide Y receptor Y2, [RH, Score=178, Expect=9e-51]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [RH, Score=176, Expect=3e-50]; ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=176, Expect=1e-49]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [Score=245, Expect=4e-74]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=215, Expect=5e-65]} {Smed: dd_Smed_v6_15335_0_1, dd_Smed_v6_15335_0_1, [RH, Score=313, Expect=2e-103]} {RNA1310_18147.1} {RNA815_7986} Mlig455_070456 {REF} {Length: 3569} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=176.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=29.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.3]} {Human: ENSG00000185149, NPY2R, neuropeptide Y receptor Y2, [RH, Score=177, Expect=8e-50]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [RH, Score=175, Expect=3e-49]; ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=174, Expect=2e-48]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [RH, Score=166, Expect=2e-44]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=215, Expect=4e-64]} {Smed: dd_Smed_v6_15335_0_1, dd_Smed_v6_15335_0_1, [RH, Score=315, Expect=8e-103]} {RNA1310_18147.1} {RNA815_7986} |
38. | MligTC455_43557 | 362 | 7.55 | Mlig455_059172, Mlig455_065527 | Neo: - Age: Down-Down-Up Region-specific R2: 6.284 Region-enriched R2: 5.832/0.00001 |
ANKRD63 | 1.814 | 0.956 | - | - | 0.858 | - | - | Mlig455_059172 {REF} {Length: 1739} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.2]; Ankyrin repeats (many copies) [PF13637.8, score=42.6]; Ankyrin repeat [PF13606.8, score=27.6]; Ankyrin repeats (many copies) [PF13857.8, score=27.1]; Ankyrin repeat [PF00023.32, score=25.9]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=67.4, Expect=7e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=49.3, Expect=7e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=49.3, Expect=4e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=81.3, Expect=1e-16]} {RNA1310_44826} {RNA815_62096} Mlig455_065527 {REF} {Length: 2998} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=52.3]; Ankyrin repeats (many copies) [PF13637.8, score=42.0]; Ankyrin repeats (many copies) [PF13857.8, score=26.7]; Ankyrin repeat [PF00023.32, score=26.0]; Ankyrin repeat [PF13606.8, score=22.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=68.2, Expect=6e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=50.1, Expect=5e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=50.4, Expect=2e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=80.9, Expect=2e-16]} {RNA1509_30872} {RNA1310_44826} {RNA815_62096} |
39. | MligTC455_20532 | 63 | 1.32 | Mlig455_029971 | Neo: - Age: - |
1.809 | 0.859 | - | - | 0.950 | - | - | Mlig455_029971 {REF} {Length: 1702} {Pfam: UPF0489 domain [PF12640.9, score=20.3]} {RNA1509_3030} {RNA1310_35103} {RNA815_26539} | |
40. | MligTC455_48010 | 177 | 3.69 | Mlig455_051923 | Neo: - Age: logFC(26M/2M)=-0.400 |
1.807 | 0.831 | - | - | - | 0.976 | - | Mlig455_051923 {REF} {Length: 1181} {Smed: dd_Smed_v6_2217_0_1, dd_Smed_v6_2217_0_1, [RH, Score=54.7, Expect=4e-10]} {RNA1509_30673} {RNA1310_38150} {RNA815_20383} | |
41. | MligTC455_40851 | 132 | 2.76 | Mlig455_042077 | Neo: - Age: logFC(26M/2M)=0.724 Region-enriched R2: 3.969/0.02676 |
PKD1L2 | 1.803 | 0.850 | - | - | - | 0.953 | - | Mlig455_042077 {REF} {Length: 4836} {Pfam: PLAT/LH2 domain [PF01477.25, score=68.6]; Polycystin cation channel [PF08016.14, score=53.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=220, Expect=3e-58]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=212, Expect=7e-56]} {Dmel: FBgn0050048, CG30048, [Score=55.8, Expect=2e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=122, Expect=1e-27]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=328, Expect=2e-94]} {RNA1509_8046} {RNA1310_93} {RNA815_1216} |
42. | MligTC455_40352 | 49 | 1.03 | Mlig455_024410 | Neo: - Age: - |
1.802 | 0.837 | - | - | - | 0.965 | - | Mlig455_024410 {REF} {Length: 1509} {TRANSSPLICED} {RNA1310_29008} {RNA815_41596} | |
43. | MligTC455_17778 | 198 | 4.12 | Mlig455_021327 | Neo: - Age: - |
1.795 | 0.823 | - | - | - | 0.972 | - | Mlig455_021327 {REF} {Length: 416} {TRANSSPLICED} {RNA1509_23323} {RNA1310_114939} | |
44. | MligTC455_09595 | 48 | 1.01 | Mlig455_030009 | Neo: - Age: - |
OPRM1 | 1.793 | 0.966 | - | - | 0.827 | - | - | Mlig455_030009 {REF} {Length: 1508} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=44.4]; Serpentine type 7TM GPCR chemoreceptor Sra [PF02117.18, score=19.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=19.6]} {Human: ENSG00000112038, OPRM1, opioid receptor mu 1, [Score=56.2, Expect=5e-08]} {Mouse: ENSMUSG00000000766, Oprm1, opioid receptor, mu 1, [Score=54.7, Expect=9e-08]} {Celegans: WBGene00021510, frpr-19, FMRFamide Peptide Receptor family, [Score=47.8, Expect=7e-06]} {RNA1310_43388} {RNA815_47203} |
45. | MligTC455_37988 | 67 | 1.41 | Mlig455_008561 | Neo: - Age: - Region-enriched R2: 8.988/0.00000 |
1.786 | 0.964 | - | - | 0.822 | - | - | Mlig455_008561 {REF} {Length: 3146} {Pfam: EF-hand domain pair [PF13499.8, score=36.5]; EF-hand domain [PF13405.8, score=31.2]; EF hand [PF00036.34, score=29.3]; EF-hand domain pair [PF13833.8, score=20.4]; EF hand [PF13202.8, score=19.4]} {Smed: dd_Smed_v6_1010_0_1, dd_Smed_v6_1010_0_1, [Score=104, Expect=1e-26]} {RNA1310_31713.1} {RNA815_36423} | |
46. | MligTC455_26844 | 103 | 2.16 | Mlig455_015617, Mlig455_069803 | Neo: - Age: - |
1.784 | - | - | 0.826 | - | 0.958 | - | Mlig455_015617 {REF} {Length: 1071} {Celegans: WBGene00019136, F59H6.5, [Score=90.9, Expect=1e-19]} {RNA1509_13878} {RNA1310_8770} {RNA815_4829.1} Mlig455_069803 {REF} {Length: 6022} {Pfam: Helitron helicase-like domain at N-terminus [PF14214.8, score=176.0]} {Celegans: WBGene00022692, ZK250.9, [Score=281, Expect=9e-82]} {RNA1509_18422} {RNA1310_8770, RNA1509_18422} {RNA1509_18422, RNA815_4829.1} |
|
47. | MligTC455_26653 | 3263 | 67.97 | Mlig455_049144, Mlig455_049196 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.518 Region-specific R3: 7.699 Region-enriched R3: 6.693/0.00000 |
1.781 | - | - | 0.974 | 0.807 | - | - | Mlig455_049144 {REF} {Length: 862} {Pfam: CUB domain [PF00431.22, score=21.5]} {RNA1509_5316} {RNA1310_45244} {RNA815_23025} Mlig455_049196 {REF} {Length: 3464} {Pfam: CUB domain [PF00431.22, score=21.5]} {RNA1509_23994, RNA1509_5316} {RNA1310_45244, RNA1509_23994, RNA1509_5316} {RNA1509_23994, RNA1509_5316, RNA815_23025} |
|
48. | MligTC455_22400 | 2410 | 50.2 | Mlig455_049145 | Neo: - Age: logFC(26M/2M)=0.314 Region-enriched R3: 6.393/0.00000 |
1.779 | - | - | 0.960 | 0.819 | - | - | Mlig455_049145 {REF} {Length: 929} {RNA1509_6763, RNA1509_7997} {RNA1310_46088, RNA1509_6763, RNA1509_7997} {RNA1509_6763, RNA1509_7997, RNA815_22985} | |
49. | MligTC455_19783 | 37 | 0.78 | Mlig455_022120 | Neo: - Age: - |
ACE | 1.776 | 0.972 | - | - | 0.804 | - | - | Mlig455_022120 {REF} {Length: 2567} {Pfam: Angiotensin-converting enzyme [PF01401.20, score=634.0]} {Human: ENSG00000159640, ACE, angiotensin I converting enzyme, [Score=434, Expect=6e-143]; ENSG00000264813, AC113554.1, novel transcript, [Score=432, Expect=5e-142]} {Mouse: ENSMUSG00000020681, Ace, angiotensin I converting enzyme (peptidyl-dipeptidase A) 1, [Score=439, Expect=7e-145]} {Dmel: FBgn0012037, Ance, Angiotensin converting enzyme, [RH, Score=438, Expect=3e-146]} {Celegans: WBGene00000039, acn-1, Inactive angiotensin-converting enzyme-related protein, [Score=186, Expect=1e-49]} {Smed: dd_Smed_v6_6160_0_1, dd_Smed_v6_6160_0_1, [Score=353, Expect=6e-113]} {RNA1509_47279} {RNA1310_39654} {RNA815_34873} |
50. | MligTC455_44588 | 393 | 8.19 | Mlig455_029075 | Neo: - |
CASP8 | 1.769 | 0.812 | - | - | - | 0.957 | - | Mlig455_029075 {REF} {Length: 2730} {Pfam: Caspase domain [PF00656.24, score=122.9]; Ankyrin repeats (3 copies) [PF12796.9, score=78.1]; Ankyrin repeats (many copies) [PF13637.8, score=65.6]; Ankyrin repeat [PF13606.8, score=61.3]; Ankyrin repeats (many copies) [PF13857.8, score=58.2]; Ankyrin repeat [PF00023.32, score=55.5]} {Human: ENSG00000064012, CASP8, caspase 8, [RH, Score=183, Expect=1e-50]} {Mouse: ENSMUSG00000026029, Casp8, caspase 8, [RH, Score=194, Expect=5e-55]} {Dmel: FBgn0019972, Drice, Death related ICE-like caspase, [Score=149, Expect=4e-40]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=128, Expect=5e-33]} {Smed: dd_Smed_v6_4986_0_1, dd_Smed_v6_4986_0_1, [Score=127, Expect=3e-33]} {RNA1509_39135, RNA1509_56179} {RNA1310_8056, RNA1509_39135, RNA1509_56179} {RNA1509_39135, RNA1509_56179, RNA815_3832.1} |
51. | MligTC455_42902 | 28 | 0.59 | Mlig455_017220 | Neo: - Age: - |
1.768 | - | - | 0.961 | - | 0.807 | - | Mlig455_017220 {REF} {Length: 656} {NoTransDecoderORF} {RNA1509_43125} {RNA1310_24647} {RNA815_24974} | |
52. | MligTC455_40852 | 128 | 2.66 | Mlig455_042301 | Neo: - Age: Up-Up-Down, logFC(26M/2M)=0.671 Region-enriched R2: 6.158/0.00357 |
PKDREJ | 1.764 | 0.797 | - | - | - | 0.967 | - | Mlig455_042301 {REF} {Length: 11184} {Pfam: Polycystin cation channel [PF08016.14, score=273.5]; PKD domain [PF00801.22, score=86.2]; PLAT/LH2 domain [PF01477.25, score=67.1]; REJ domain [PF02010.17, score=66.8]; PKD domain [PF18911.2, score=62.3]; Ion transport protein [PF00520.33, score=45.4]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=283, Expect=2e-75]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=273, Expect=2e-72]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=158, Expect=3e-38]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=254, Expect=4e-67]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=514, Expect=2e-146]} {RNA1509_8046} {RNA1310_93, RNA1509_8046} {RNA1509_8046, RNA815_1216} |
53. | MligTC455_24267 | 26 | 0.54 | Mlig455_005114, Mlig455_005116, Mlig455_005118 | Neo: - Age: - |
CHRNA7 | 1.758 | 0.787 | - | 0.971 | - | - | - | Mlig455_005114 {REF} {Length: 1666} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=114.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=64.3]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=146, Expect=3e-38]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=143, Expect=3e-37]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=144, Expect=9e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=138, Expect=9e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=134, Expect=8e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=1e-34]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=135, Expect=1e-34]} {RNA1509_43533} {RNA1310_21349.1} {RNA815_22406} Mlig455_005116 {REF} {Length: 1663} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=114.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=63.3]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=146, Expect=3e-38]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=143, Expect=3e-37]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=144, Expect=8e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=138, Expect=9e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=134, Expect=9e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=1e-34]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=135, Expect=1e-34]} {RNA1509_43533} {RNA1310_21349.1} {RNA815_22406} Mlig455_005118 {REF} {Length: 1662} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=114.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=63.3]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=146, Expect=3e-38]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=143, Expect=3e-37]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=144, Expect=8e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=138, Expect=9e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=134, Expect=9e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=1e-34]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=135, Expect=1e-34]} {RNA1509_43533} {RNA1310_21349.1} {RNA815_22406} |
54. | MligTC455_52726 | 213 | 4.44 | Mlig455_032119 | Neo: - Age: - Region-enriched R2: 4.573/0.00005 |
1.757 | 0.962 | - | - | 0.795 | - | - | Mlig455_032119 {REF} {Length: 2626} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=61.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=21.0]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=137, Expect=2e-37]} {RNA1509_41314} {RNA1310_26265} {RNA815_9794.1} | |
55. | MligTC455_47735 | 70 | 1.45 | Mlig455_054644 | Neo: - Age: - Region-enriched R3: 5.950/0.00023 |
1.753 | - | - | 0.968 | 0.785 | - | - | Mlig455_054644 {REF} {Length: 804} {Pfam: Domain of unknown function (DUF4573) [PF15140.8, score=37.7]} {RNA1509_39145} {RNA1310_42379.1} {RNA815_34286.1} | |
56. | MligTC455_50740 | 262 | 5.46 | Mlig455_028088 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.630/0.00016 |
SFRP5 | 1.752 | 0.799 | - | - | - | 0.953 | - | Mlig455_028088 {REF} {Length: 2548} {Pfam: Fz domain [PF01392.24, score=93.7]} {Human: ENSG00000120057, SFRP5, secreted frizzled related protein 5, [RH, Score=158, Expect=5e-44]} {Mouse: ENSMUSG00000018822, Sfrp5, secreted frizzled-related sequence protein 5, [RH, Score=156, Expect=2e-43]} {Dmel: FBgn0027342, fz4, frizzled 4, [Score=100, Expect=4e-22]} {Celegans: WBGene00022242, sfrp-1, Secreted Frizzled-Related Protein, [RH, Score=163, Expect=2e-46]} {Smed: dd_Smed_v6_13985_0_1, dd_Smed_v6_13985_0_1, [RH, Score=164, Expect=2e-46]} {RNA1509_19129} {RNA1310_15120} {RNA815_30861} |
57. | MligTC455_42813 | 43 | 0.89 | Mlig455_003111 | Neo: - Age: - |
1.744 | - | - | - | 0.953 | 0.791 | - | Mlig455_003111 {REF} {Length: 1922} {NoTransDecoderORF} {RNA1509_47921} {RNA1310_3669} {RNA815_8730.1} | |
58. | MligTC455_12878 | 91 | 1.89 | Mlig455_025598, Mlig455_052895 | Neo: - Age: - |
1.741 | - | - | 1.000 | 0.741 | - | - | Mlig455_025598 {REF} {Length: 345} {NoTransDecoderORF} {RNA1310_75777} Mlig455_052895 {REF} {Length: 467} {NoTransDecoderORF} {RNA1310_75777} |
|
59. | MligTC455_28787 | 30 | 0.62 | Mlig455_043846, Mlig455_054188, Mlig455_060734 | Neo: - Age: logFC(26M/2M)=-0.737 |
ANKRD50 | 1.741 | - | - | 0.987 | - | 0.754 | - | Mlig455_043846 {REF} {Length: 665} {Pfam: DDE superfamily endonuclease [PF13358.8, score=23.1]} {Smed: dd_Smed_v6_42273_0_1, dd_Smed_v6_42273_0_1, [RH, Score=43.1, Expect=6e-06]} Mlig455_054188 {REF} {Length: 3683} {Pfam: Mab-21 protein [PF03281.16, score=27.1]} {RNA1509_27730} {RNA1310_30964} {RNA815_2387.1} Mlig455_060734 {REF} {Length: 6592} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=88.1]; Ankyrin repeats (many copies) [PF13637.8, score=65.2]; Ankyrin repeats (many copies) [PF13857.8, score=58.9]; Ankyrin repeat [PF13606.8, score=53.0]; Ankyrin repeat [PF00023.32, score=41.3]; Mab-21 protein [PF03281.16, score=25.4]} {Human: ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=86.3, Expect=3e-16]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=89.7, Expect=2e-17]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=74.7, Expect=6e-13]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [Score=71.6, Expect=3e-12]} {Smed: dd_Smed_v6_6779_0_1, dd_Smed_v6_6779_0_1, [Score=84.0, Expect=4e-16]} {RNA1509_27730} {RNA1310_24666.1} {RNA815_2426.1} |
60. | MligTC455_47295 | 21 | 0.43 | Mlig455_036828 | Neo: - Age: - |
1.74 | - | - | - | 0.951 | 0.789 | - | Mlig455_036828 {REF} {Length: 1579} {Pfam: TMEM206 protein family [PF15122.8, score=63.7]} {RNA1310_18723} {RNA815_19071} | |
61. | MligTC455_13571 | 22 | 0.46 | Mlig455_017396 | Neo: - Age: - |
1.733 | - | - | 0.968 | - | 0.765 | - | Mlig455_017396 {REF} {Length: 2929} {Pfam: Domain of unknown function (DUF4834) [PF16118.7, score=23.0]; Transmembrane protein 51 [PF15345.8, score=21.9]; RNA polymerase I-specific transcription-initiation factor [PF10214.11, score=20.8]; Ctr copper transporter family [PF04145.17, score=20.5]; ARC105 or Med15 subunit of Mediator complex non-fungal [PF09606.12, score=19.0]; Mechanosensitive ion channel inner membrane domain 1 [PF12794.9, score=17.5]} {RNA1310_13412} {RNA815_37792} | |
62. | MligTC455_31034 | 1413 | 29.44 | Mlig455_010209 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.073/0.00063 Regeneration-downregulated R2: -3.891 Regeneration-depleted R2: -3.891 |
1.73 | 0.780 | - | - | 0.950 | - | - | Mlig455_010209 {REF} {Length: 491} {RNA1509_11492} {RNA1310_85216} {RNA815_25478.2} | |
63. | MligTC455_34693 | 336 | 7 | Mlig455_017459 | Neo: - Age: - Region-enriched R2: 6.024/0.00000 |
FZD4 | 1.726 | 0.960 | - | - | 0.766 | - | - | Mlig455_017459 {REF} {Length: 3882} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=335.8]; Fz domain [PF01392.24, score=90.0]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=424, Expect=3e-141]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=423, Expect=3e-141]} {Dmel: FBgn0001085, fz, frizzled, [Score=306, Expect=2e-95]} {Celegans: WBGene00003006, lin-17, Transmembrane receptor LIN-17, [RH, Score=271, Expect=1e-82]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=473, Expect=3e-160]} {RNA1509_10294} {RNA1310_2672} {RNA815_3209} |
64. | MligTC455_45461 | 19 | 0.39 | Mlig455_048774 | Neo: - Age: - |
1.726 | 0.767 | - | 0.959 | - | - | - | Mlig455_048774 {REF} {Length: 1674} {RNA1310_83162} {RNA815_51076} | |
65. | MligTC455_26585 | 173 | 3.61 | Mlig455_061024 | Neo: - Age: - |
1.723 | 0.748 | - | - | - | 0.975 | - | Mlig455_061024 {REF} {Length: 2825} {RNA1509_19437} {RNA1310_38787} {RNA815_16416} | |
66. | MligTC455_34838 | 79 | 1.65 | Mlig455_055037, Mlig455_055054 | Neo: - Age: logFC(26M/2M)=-0.508 |
MAN1A2, MAN1C1 | 1.704 | 0.744 | - | - | - | 0.960 | - | Mlig455_055037 {REF} {Length: 2154} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=152.3]} {Human: ENSG00000117643, MAN1C1, mannosidase alpha class 1C member 1, [Score=97.1, Expect=8e-23]; ENSG00000177239, MAN1B1, mannosidase alpha class 1B member 1, [Score=94.7, Expect=7e-22]; ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=94.0, Expect=3e-22]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=97.1, Expect=7e-23]; ENSMUSG00000037306, Man1c1, mannosidase, alpha, class 1C, member 1, [Score=95.9, Expect=2e-22]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=82.8, Expect=5e-18]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=77.0, Expect=3e-16]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=88.2, Expect=3e-20]} {RNA1509_49063} {RNA1310_10155.1} {RNA815_4503.1} Mlig455_055054 {REF} {Length: 2620} {Pfam: Glycosyl hydrolase family 47 [PF01532.22, score=372.1]} {Human: ENSG00000198162, MAN1A2, mannosidase alpha class 1A member 2, [Score=254, Expect=1e-76]; ENSG00000111885, MAN1A1, mannosidase alpha class 1A member 1, [Score=242, Expect=9e-72]} {Mouse: ENSMUSG00000008763, Man1a2, mannosidase, alpha, class 1A, member 2, [Score=256, Expect=2e-77]} {Dmel: FBgn0259170, alpha-Man-Ia, alpha-Mannosidase class I a, [Score=248, Expect=3e-74]} {Celegans: WBGene00008258, mans-2, Mannosyl-oligosaccharide 1,2-alpha-mannosidase C52E4.5, [Score=239, Expect=1e-71]} {Smed: dd_Smed_v6_6801_0_1, dd_Smed_v6_6801_0_1, [Score=267, Expect=4e-82]} {RNA1509_40257, RNA1509_47963} {RNA1310_10155.1, RNA1509_47963} {RNA1509_47963, RNA815_4503.1} |
67. | MligTC455_37917 | 34 | 0.71 | Mlig455_070471 | Neo: - Age: - |
1.702 | 0.712 | - | 0.990 | - | - | - | Mlig455_070471 {REF} {Length: 638} {NoTransDecoderORF} {RNA1310_105024} | |
68. | MligTC455_17843 | 74 | 1.55 | Mlig455_010069, Mlig455_063252, Mlig455_063277 | Neo: - Age: - |
1.694 | - | - | 0.955 | - | 0.739 | - | Mlig455_010069 {REF} {Length: 64} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_42489} {RNA1310_14879} {RNA815_7053} Mlig455_063252 {REF} {Length: 64} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_42489} {RNA1310_14879} {RNA815_7053} Mlig455_063277 {REF} {Length: 64} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_42489} {RNA1310_14879} {RNA815_7053} |
|
69. | MligTC455_27650 | 178 | 3.72 | Mlig455_017720 | Neo: - Age: logFC(26M/2M)=-0.928 Region-enriched R2: 3.586/0.00082 |
ADAM33 | 1.694 | 0.733 | - | - | - | 0.961 | - | Mlig455_017720 {REF} {Length: 4499} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=124.3]; Disintegrin [PF00200.25, score=66.8]; Metallo-peptidase family M12 [PF13688.8, score=62.2]; ADAM cysteine-rich [PF08516.14, score=61.3]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=33.1]} {Human: ENSG00000149451, ADAM33, ADAM metallopeptidase domain 33, [Score=237, Expect=1e-64]; ENSG00000151651, ADAM8, ADAM metallopeptidase domain 8, [Score=233, Expect=2e-63]; ENSG00000168615, ADAM9, ADAM metallopeptidase domain 9, [Score=230, Expect=2e-62]; ENSG00000148848, ADAM12, ADAM metallopeptidase domain 12, [Score=228, Expect=4e-61]; ENSG00000069206, ADAM7, ADAM metallopeptidase domain 7, [Score=226, Expect=4e-61]; ENSG00000042980, ADAM28, ADAM metallopeptidase domain 28, [Score=226, Expect=4e-61]} {Mouse: ENSMUSG00000079058, Adam34, a disintegrin and metallopeptidase domain 34, [RH, Score=248, Expect=4e-69]; ENSMUSG00000050190, Gm5346, predicted gene 5346, [RH, Score=239, Expect=3e-66]} {Dmel: FBgn0265140, Meltrin, [RH, Score=288, Expect=1e-79]} {Celegans: WBGene00000074, adm-2, ADAM (Disintegrin plus metalloprotease) family, [Score=246, Expect=3e-67]} {Smed: dd_Smed_v6_5143_0_1, dd_Smed_v6_5143_0_1, [Score=225, Expect=3e-60]} {RNA1509_7654} {RNA1310_9319.1} {RNA815_4173.1} |
70. | MligTC455_36286 | 2583 | 53.81 | Mlig455_049146 | Neo: - Age: Down-Down-Up Region-enriched R3: 6.207/0.00000 |
1.694 | - | - | 0.952 | 0.742 | - | - | Mlig455_049146 {REF} {Length: 746} {Pfam: CUB domain [PF00431.22, score=28.0]} {RNA1509_1672} {RNA1310_53620, RNA1509_1672} {RNA1509_1672, RNA815_26829} | |
71. | MligTC455_48255 | 87 | 1.81 | Mlig455_037389 | Neo: - |
1.689 | - | - | 0.965 | 0.724 | - | - | Mlig455_037389 {REF} {Length: 2777} {Pfam: Lectin C-type domain [PF00059.23, score=38.1]} {RNA1310_22051} {RNA815_28288} | |
72. | MligTC455_53480 | 31 | 0.64 | Mlig455_043390, Mlig455_043414, Mlig455_043557 | Neo: - Age: - |
WSCD2 | 1.677 | 0.972 | - | - | - | 0.705 | - | Mlig455_043390 {REF} {Length: 1215} {Pfam: WSC domain [PF01822.21, score=50.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=59.7, Expect=2e-10]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=59.7, Expect=2e-10]} {RNA1310_30552} {RNA815_18175} Mlig455_043414 {REF} {Length: 1144} {Pfam: WSC domain [PF01822.21, score=46.1]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=56.2, Expect=8e-09]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=57.4, Expect=3e-09]} {RNA1310_30552} {RNA815_18175} Mlig455_043557 {REF} {Length: 1209} {Pfam: WSC domain [PF01822.21, score=32.4]} {RNA1310_30552} {RNA815_18175} |
73. | MligTC455_39481 | 461 | 9.6 | Mlig455_056703, Mlig455_060318 | Neo: - Age: Down-Up-Up Region-specific R2: 4.222 |
ANGPTL1 | 1.672 | 0.710 | - | - | - | 0.962 | - | Mlig455_056703 {REF} {Length: 1114} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=79.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=89.4, Expect=1e-19]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=85.1, Expect=3e-18]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=91.3, Expect=2e-20]} {Dmel: FBgn0033312, CG8642, [Score=82.4, Expect=1e-17]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=76.3, Expect=1e-15]} {RNA1310_31288} {RNA815_20497.1} Mlig455_060318 {REF} {Length: 1175} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=106, Expect=2e-25]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=6e-26]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=109, Expect=1e-26]} {Dmel: FBgn0034160, CG5550, [Score=96.3, Expect=2e-23]} {Celegans: WBGene00016769, C49C8.5, [Score=47.0, Expect=9e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=88.2, Expect=2e-19]} {RNA1310_31288} {RNA815_20497.1} |
74. | MligTC455_40403 | 9540 | 198.75 | Mlig455_012883 | Neo: - Age: - |
1.671 | 0.720 | - | - | - | 0.951 | - | Mlig455_012883 {REF} {Length: 2696} {RNA1509_3465, RNA1509_49920, RNA1509_5573} {RNA1310_95894.2, RNA1509_3465, RNA1509_49920, RNA1509_5573} {RNA1509_3465, RNA1509_49920, RNA1509_5573, RNA815_48924} | |
75. | MligTC455_19796 | 59 | 1.22 | Mlig455_022720 | Neo: - Age: Up-Up-Up, logFC(26M/2M)=1.691 Region-enriched R4: 4.274/0.04456 |
0.999 | - | - | 0.999 | - | - | - | Mlig455_022720 {REF} {Length: 1270} {RNA1310_22076} {RNA815_30973} | |
76. | MligTC455_30325 | 15 | 0.31 | Mlig455_043329 | Neo: - Age: - |
NYNRIN | 0.999 | - | - | - | - | 0.999 | - | Mlig455_043329 {REF} {Length: 3260} {Pfam: Integrase zinc binding domain [PF17921.3, score=79.6]; Integrase core domain [PF00665.28, score=56.1]} {Human: ENSG00000205978, NYNRIN, NYN domain and retroviral integrase containing, [Score=118, Expect=7e-27]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=122, Expect=3e-28]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=207, Expect=1e-59]} {RNA1509_29299} {RNA1310_18534} {RNA815_7746} |
77. | MligTC455_06967 | 28 | 0.59 | Mlig455_016951 | Neo: - Age: - |
GPR158 | 0.998 | - | - | - | - | 0.998 | - | Mlig455_016951 {REF} {Length: 2780} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=103.8]} {Human: ENSG00000151025, GPR158, G protein-coupled receptor 158, [Score=221, Expect=5e-62]} {Mouse: ENSMUSG00000045967, Gpr158, G protein-coupled receptor 158, [Score=226, Expect=5e-64]; ENSMUSG00000070337, Gpr179, G protein-coupled receptor 179, [Score=220, Expect=9e-62]} {Dmel: FBgn0051660, smog, [RH, Score=276, Expect=4e-83]} {Celegans: WBGene00009558, F39B2.8, [Score=191, Expect=4e-54]} {Smed: dd_Smed_v6_8408_0_1, dd_Smed_v6_8408_0_1, [RH, Score=365, Expect=4e-119]} {RNA1509_29274} {RNA1310_5195} {RNA815_2660} |
78. | MligTC455_07259 | 35 | 0.73 | Mlig455_039676 | Neo: - |
PNLIPRP1 | 0.998 | - | - | - | 0.998 | - | - | Mlig455_039676 {REF} {Length: 1808} {Pfam: Lipase [PF00151.21, score=323.9]; alpha/beta hydrolase fold [PF00561.22, score=19.0]} {Human: ENSG00000187021, PNLIPRP1, pancreatic lipase related protein 1, [RH, Score=312, Expect=5e-101]} {Mouse: ENSMUSG00000042179, Pnliprp1, pancreatic lipase related protein 1, [RH, Score=317, Expect=6e-103]; ENSMUSG00000025091, Pnliprp2, pancreatic lipase-related protein 2, [RH, Score=305, Expect=2e-98]} {Dmel: FBgn0029831, CG5966, [RH, Score=228, Expect=5e-68]} {RNA1509_25173} {RNA1310_15349, RNA1509_25173} {RNA1509_25173, RNA815_20151} |
79. | MligTC455_25464 | 185 | 3.85 | Mlig455_001339 | Neo: - Age: - Region-enriched R2: 4.725/0.00025 |
0.998 | - | - | - | - | 0.998 | - | Mlig455_001339 {REF} {Length: 1386} {RNA1509_58508} {RNA1310_32754, RNA1509_58508} {RNA1509_58508, RNA815_47065} | |
80. | MligTC455_42510 | 125 | 2.6 | Mlig455_025998, Mlig455_070424 | Neo: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_025998 {REF} {Length: 1369} {RNA1310_73875.1} Mlig455_070424 {REF} {Length: 1082} {RNA1310_73875.1} |
|
81. | MligTC455_49228 | 14 | 0.28 | Mlig455_052327 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_052327 {REF} {Length: 1429} {Smed: dd_Smed_v6_47882_0_1, dd_Smed_v6_47882_0_1, [Score=45.4, Expect=1e-05]} {RNA1310_43249} | |
82. | MligTC455_12405 | 12 | 0.25 | Mlig455_052412, Mlig455_060453 | Neo: - Age: - |
0.997 | - | - | - | - | 0.997 | - | Mlig455_052412 {REF} {Length: 897} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [Score=63.5, Expect=4e-12]} {RNA1310_37660} {RNA815_17816.1} Mlig455_060453 {REF} {Length: 900} {Pfam: PAN domain [PF00024.28, score=19.1]} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [RH, Score=71.2, Expect=8e-15]} {RNA1310_37660} {RNA815_17816.1} |
|
83. | MligTC455_17412 | 44 | 0.91 | Mlig455_069737 | Neo: - Age: - Region-enriched R2: 5.062/0.00923 |
0.997 | - | - | - | - | 0.997 | - | Mlig455_069737 {REF} {Length: 1628} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=42.8]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=72.8, Expect=3e-14]} {RNA1310_45758} {RNA815_42912} | |
84. | MligTC455_18700 | 19 | 0.4 | Mlig455_003655 | Neo: - Age: - |
0.997 | - | - | 0.997 | - | - | - | Mlig455_003655 {REF} {Length: 471} {NoTransDecoderORF} {RNA1310_85204} | |
85. | MligTC455_19042 | 3679 | 76.64 | Mlig455_030661 | Neo: - Age: logFC(26M/2M)=0.480 Region-specific R2: 2.811 Region-enriched R2: 1.755/0.00003 |
CAV1 | 0.997 | - | - | - | - | 0.997 | - | Mlig455_030661 {REF} {Length: 1257} {Pfam: Caveolin [PF01146.19, score=124.8]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=105, Expect=2e-29]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=105, Expect=2e-29]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [RH, Score=81.6, Expect=8e-20]} {Smed: dd_Smed_v6_13481_0_1, dd_Smed_v6_13481_0_1, [RH, Score=144, Expect=1e-45]} {RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522} {RNA1310_31540, RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522} {RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522, RNA815_14585} |
86. | MligTC455_43352 | 95 | 1.98 | Mlig455_036042, Mlig455_036143, Mlig455_036169 | Neo: - Age: - |
0.997 | - | - | - | - | 0.997 | - | Mlig455_036042 {REF} {Length: 601} {NoTransDecoderORF} {RNA1310_52240} {RNA815_32818} Mlig455_036143 {REF} {Length: 706} {RNA1310_52240} {RNA815_32818} Mlig455_036169 {REF} {Length: 944} {NoTransDecoderORF} {RNA1310_52240} {RNA815_32818} |
|
87. | MligTC455_45851 | 33 | 0.69 | Mlig455_020386 | Neo: - Age: - |
0.997 | - | - | 0.997 | - | - | - | Mlig455_020386 {REF} {Length: 590} {RNA1509_48193} {RNA1310_97125} | |
88. | MligTC455_52861 | 31 | 0.64 | Mlig455_049513 | Neo: - Age: - |
GNAO1 | 0.997 | - | - | 0.997 | - | - | - | Mlig455_049513 {REF} {Length: 3228} {Pfam: G-protein alpha subunit [PF00503.22, score=252.5]; ADP-ribosylation factor family [PF00025.23, score=43.6]; Rad17 P-loop domain [PF03215.17, score=22.1]; AAA ATPase domain [PF13191.8, score=19.2]} {Human: ENSG00000087258, GNAO1, G protein subunit alpha o1, [Score=152, Expect=4e-40]; ENSG00000114353, GNAI2, G protein subunit alpha i2, [Score=147, Expect=2e-38]} {Mouse: ENSMUSG00000032562, Gnai2, guanine nucleotide binding protein (G protein), alpha inhibiting 2, [Score=149, Expect=2e-39]; ENSMUSG00000031748, Gnao1, guanine nucleotide binding protein, alpha O, [Score=149, Expect=2e-39]; ENSMUSG00000057614, Gnai1, guanine nucleotide binding protein (G protein), alpha inhibiting 1, [Score=143, Expect=4e-37]; ENSMUSG00000000001, Gnai3, guanine nucleotide binding protein (G protein), alpha inhibiting 3, [Score=142, Expect=1e-36]} {Dmel: FBgn0001104, Galphai, G protein alpha i subunit, [Score=150, Expect=1e-39]} {Celegans: WBGene00001677, gpa-15, Guanine nucleotide-binding protein alpha-15 subunit, [Score=156, Expect=4e-42]} {Smed: dd_Smed_v6_22522_0_2, dd_Smed_v6_22522_0_2, [RH, Score=231, Expect=9e-69]} {RNA1509_23459} {RNA1310_51930} {RNA815_22610} |
89. | MligTC455_13885 | 28 | 0.58 | Mlig455_020919 | Neo: - Age: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_020919 {REF} {Length: 1208} {RNA1310_25040.4} {RNA815_12562.1} | |
90. | MligTC455_15380 | 10 | 0.2 | Mlig455_001774 | Neo: - Age: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_001774 {REF} {Length: 978} {NoTransDecoderORF} {RNA1310_143116} | |
91. | MligTC455_19064 | 1659 | 34.56 | Mlig455_029479 | Neo: - Age: logFC(26M/2M)=-0.425 Region-enriched R2: 4.582/0.01945 |
MOXD1 | 0.996 | - | - | - | - | 0.996 | - | Mlig455_029479 {REF} {Length: 2454} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=57.5]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=55.7]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=85.1, Expect=1e-16]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=95.1, Expect=5e-20]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=82.0, Expect=6e-16]} {RNA1509_10910, RNA1509_383, RNA1509_4965, RNA1509_52547, RNA1509_7121} {RNA1310_17053.1, RNA1509_10910, RNA1509_4965, RNA1509_52547, RNA1509_7121} {RNA1509_10910, RNA1509_4965, RNA1509_52547, RNA1509_7121, RNA815_3799} |
92. | MligTC455_24716 | 8 | 0.17 | Mlig455_059952 | Neo: - Age: Down-Up-Down |
MARCH8 | 0.996 | - | - | - | - | 0.996 | - | Mlig455_059952 {REF} {Length: 2107} {TRANSSPLICED} {Pfam: RING-variant domain [PF12906.9, score=56.5]} {Human: ENSG00000165406, MARCH8, membrane associated ring-CH-type finger 8, [RH, Score=226, Expect=7e-69]; ENSG00000145416, MARCH1, membrane associated ring-CH-type finger 1, [RH, Score=223, Expect=5e-68]; ENSG00000278545, MARCH8, membrane associated ring-CH-type finger 8, [RH, Score=220, Expect=3e-70]} {Mouse: ENSMUSG00000025702, March8, membrane-associated ring finger (C3HC4) 8, [RH, Score=228, Expect=4e-73]; ENSMUSG00000036469, March1, membrane-associated ring finger (C3HC4) 1, [RH, Score=226, Expect=6e-72]} {Dmel: FBgn0035983, CG4080, [RH, Score=222, Expect=5e-67]} {Celegans: WBGene00007643, marc-3, MARCH (Membrane-Associated Ring finger (C3HC4)) homolog, [RH, Score=67.8, Expect=2e-12]} {Smed: dd_Smed_v6_4997_0_2, dd_Smed_v6_4997_0_2, [RH, Score=244, Expect=7e-78]} {RNA1509_23175} {RNA1310_20001, RNA1509_23175} {RNA1509_23175, RNA815_11300} |
93. | MligTC455_30326 | 16 | 0.34 | Mlig455_043331 | Neo: - Age: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_043331 {REF} {Length: 1862} {RNA1509_29299} {RNA1310_70970} {RNA815_35302} | |
94. | MligTC455_38326 | 37 | 0.76 | Mlig455_038988 | Neo: - Age: - |
TNC | 0.996 | - | - | - | - | 0.996 | - | Mlig455_038988 {REF} {Length: 1782} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=73.1]} {Human: ENSG00000041982, TNC, tenascin C, [Score=71.2, Expect=1e-13]; ENSG00000116147, TNR, tenascin R, [Score=68.9, Expect=7e-13]} {Mouse: ENSMUSG00000015829, Tnr, tenascin R, [Score=67.0, Expect=3e-12]; ENSMUSG00000028364, Tnc, tenascin C, [Score=65.9, Expect=7e-12]} {Dmel: FBgn0034160, CG5550, [Score=88.2, Expect=7e-21]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=61.2, Expect=7e-11]} {RNA1310_35490} {RNA815_33352} |
95. | MligTC455_44380 | 28 | 0.58 | Mlig455_000679, Mlig455_000682, Mlig455_000734 | Neo: - Age: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_000679 {REF} {Length: 966} {Pfam: PAN domain [PF00024.28, score=22.4]} {RNA1310_44307} {RNA815_33128} Mlig455_000682 {REF} {Length: 1005} {Pfam: WSC domain [PF01822.21, score=41.4]; PAN domain [PF00024.28, score=21.7]} {RNA1310_44307} {RNA815_33128} Mlig455_000734 {REF} {Length: 1006} {Pfam: WSC domain [PF01822.21, score=41.4]; PAN domain [PF00024.28, score=21.7]} {RNA1310_44307} {RNA815_33128} |
|
96. | MligTC455_48364 | 9 | 0.2 | Mlig455_044009 | Neo: - Age: - |
LPAR1 | 0.996 | - | - | - | - | 0.996 | - | Mlig455_044009 {REF} {Length: 2040} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=50.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=41.9]; Srg family chemoreceptor [PF02118.23, score=20.9]; Serpentine type 7TM GPCR receptor class ab chemoreceptor [PF10292.11, score=20.7]; Frizzled/Smoothened family membrane region [PF01534.19, score=18.7]} {Human: ENSG00000198121, LPAR1, lysophosphatidic acid receptor 1, [Score=48.9, Expect=9e-06]} |
97. | MligTC455_57492 | 5 | 0.11 | Mlig455_009856 | Neo: - Age: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_009856 {REF} {Length: 218} {NoTransDecoderORF} {RNA1310_100871} | |
98. | MligTC455_09977 | 5 | 0.1 | Mlig455_007689 | Neo: - Age: - |
0.995 | - | - | - | - | 0.995 | - | Mlig455_007689 {REF} {Length: 1561} {Pfam: Glycine rich protein [PF12810.9, score=32.9]} {RNA1310_129878} | |
99. | MligTC455_13905 | 34 | 0.71 | Mlig455_023395 | Neo: - Age: - |
0.995 | - | - | - | - | 0.995 | - | Mlig455_023395 {REF} {Length: 1110} {Smed: dd_Smed_v6_12856_0_1, dd_Smed_v6_12856_0_1, [Score=47.0, Expect=2e-06]} {RNA1509_18233} {RNA1310_51675} {RNA815_25040} | |
100. | MligTC455_15450 | 19 | 0.39 | Mlig455_006618 | Neo: - Age: - |
0.995 | - | - | - | - | 0.995 | - | Mlig455_006618 {REF} {Length: 653} {Pfam: WSC domain [PF01822.21, score=30.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.5, Expect=7e-09]} {RNA1310_35396.1} {RNA815_56551} |